Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | BRD4 | O60885 | 12/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | USP2 | O75604 | 2/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9290441 | 0.85 | PKM (0.52) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL9290409 | 0.80 | BRD4 (0.48) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL9290356 | 0.80 | BRD4 (0.50) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL1101925 | 0.76 | KMT2A (0.62) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL9290415 | 0.76 | BRD4 (0.58) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL9290412 | 0.75 | BRD4 (0.52) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL15398140 | 0.74 | BRD4 (0.53) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL12869500 | 0.74 | KMT2A (0.73) | PKMMEN1KMT2AUSP2KEAP1 | |
| Benzene SCHEMBL28738256 | 0.74 | CYP1A2 (0.59) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL9290460 | 0.73 | BRD4 (0.53) | PKMBRD4MEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2458941-A1 | OPTICAL FILTER | Adeka Corporation (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152538-A1 | OPTICAL FILTER | C1R, CBR3, CBR1 | PKM 1698/4885BRD4 3880/4885MEN1 3537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.